Amarin's Vascepa Patents Struck Down As Generics Ramp Up
Amarin Pharma Inc. saw claims in six patents covering its blockbuster omega-3 heart drug Vascepa dashed by a Nevada federal court Monday, opening the door to generic competition and causing a...To view the full article, register now.
Already a subscriber? Click here to view full article